The Edit review
The Edit is one of the very few providers on this page that names both the medical practice writing your prescription and the pharmacy compounding it — Arora Health & Aesthetics, LLC and The Pharmacy Hub — rather than gesturing at 'licensed US providers'. Compounded semaglutide is $209 a month and tirzepatide $309, the same price at every dose, with the prescription, all injection supplies, the clinician visit and temperature-controlled two-day shipping inside that one number and no membership fee on top. First orders are $100 off, and three- and six-month plans bring the per-month equivalent down to $192 and $178 for semaglutide. It covers all 50 states and, unusually for this market, runs a complete Spanish-language version of the site rather than a machine-translated shim. The limits are real but narrow: it is compounded-only, so there is no FDA-approved Wegovy or Zepbound here, and there is no postpartum, breastfeeding or PCOS guidance anywhere on the site.
then $209/mo ongoing
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
The Edit at a glance
- Semaglutide
- $209/mo
- Tirzepatide
- $309/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored The Edit
Each score comes out of The Edit's published pricing, disclosures and oversight, and the six combine into the 77/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Fair value once you read past any teaser rate or plan structure.
Reasonable oversight, though some program details aren't fully public.
The core price is disclosed, but some conditions or add-ons aren't upfront.
Little here is shaped around a mother's week or her life stage.
Standard support — enough to stay on track, not high-touch.
Cancellation is workable but not frictionless.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- theedithealth.com/pdp-semaglutide-v1.html
$209 and $309 ongoing, after first orders discounted to $109 and $209 — the same price at every dose, no membership, cancel anytime. Compounded only: no Wegovy, Ozempic, Zepbound or Mounjaro on offer at all.
What to expect when you sign up
We walked The Edit's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action leaves theedithealth.com for start.theedithealth.com, a separate host
- 2The intake responded HTTP 200 when checked on 2026-08-21
- 3Walked to the intake entry only. No personal information was submitted, so nothing past the entry screen is asserted here
What we noticed
- The intake runs on Bask Health rather than on the provider's own software
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
- Intake is hosted on start.theedithealth.com, so the company you fill the form in with is not the domain you started on
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $109 → $209 | All doses (month to month)$109 for your first order, then $209 every month. Same price at every dose, and prescription, all injection supplies, the clinician visit and 2-day temperature-controlled shipping are inside it. |
| Compounded tirzepatide | $309 | All doses (month to month)$209 first order, then $309 every month, flat across the whole titration ladder. |
| Compounded semaglutide | $192 | 3-month plan$575 billed up front, which works out to $192/mo. |
| Compounded semaglutide | $178 | 6-month plan$1,065 up front — the cheapest per-month figure, at the cost of committing half a year. |
| Compounded tirzepatide | $285 | 3-month plan$855 billed up front, or $285/mo equivalent. |
| Compounded tirzepatide | $263 | 6-month plan$1,575 up front for six months of tirzepatide. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from The Edit's public disclosures at last review and change often; confirm the current number on The Edit's own site.
What we like
- Names both the prescribing practice (Arora Health & Aesthetics) and the compounding pharmacy (The Pharmacy Hub) — most competitors name neither
- Flat price at every dose, so the bill doesn't rise as you titrate
- Prescription, all injection supplies, clinician visit and 2-day temperature-controlled shipping included, with no membership fee
- $100 off the first order, applied automatically rather than behind a code
- A complete Spanish-language version of the site, not a machine translation
- All 50 states
The caveats
- Compounded only — no FDA-approved Wegovy, Ozempic, Zepbound or Mounjaro
- $209 and $309 sit above the cheapest compounded options on this page
- The $109 and $209 first-order prices are promotional; budget on the ongoing rate
- The cheapest per-month figures require committing three or six months up front
- No postpartum, breastfeeding or PCOS guidance anywhere on the site
- Its pharmacy also fills for other brands on this page, which is ordinary but worth knowing
The Edit for mothers: our verdict
The Edit is one of the very few providers on this page that names both the medical practice writing your prescription and the pharmacy compounding it — Arora Health & Aesthetics, LLC and The Pharmacy Hub — rather than gesturing at 'licensed US providers'. Compounded semaglutide is $209 a month and tirzepatide $309, the same price at every dose, with the prescription, all injection supplies, the clinician visit and temperature-controlled two-day shipping inside that one number and no membership fee on top. First orders are $100 off, and three- and six-month plans bring the per-month equivalent down to $192 and $178 for semaglutide. It covers all 50 states and, unusually for this market, runs a complete Spanish-language version of the site rather than a machine-translated shim. The limits are real but narrow: it is compounded-only, so there is no FDA-approved Wegovy or Zepbound here, and there is no postpartum, breastfeeding or PCOS guidance anywhere on the site. The advertised entry is $109, but the standing rate settles near $209/month — so read the headline as a starting offer, not the real monthly cost.
We weigh The Edit the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What The Edit actually costs
- Compounded semaglutide — All doses (month to month): $109 to start, then $209/mo
- Compounded tirzepatide — All doses (month to month): $309/mo
- Compounded semaglutide — 3-month plan: $192/mo
- Compounded semaglutide — 6-month plan: $178/mo
- Compounded tirzepatide — 3-month plan: $285/mo
- Compounded tirzepatide — 6-month plan: $263/mo
For context, the typical ongoing price across our roster is around $179/month, so The Edit sits at the premium end.
The medications The Edit prescribes
The Edit prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where The Edit fits — and where it doesn't — for mothers
Worth it if…
- you want a real clinician reading your history around the real monthly cost once the dose climbs, not an auto-approving quiz.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in The Edit's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
The Edit is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want to know the name of the practice prescribing and the pharmacy compounding before they pay, and who value one flat price that includes supplies and shipping.
Alternatives to The Edit
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing The Edit
Head-to-head & alternatives
The Edit, answered
- What does The Edit cost after the first month?
- $209 a month for compounded semaglutide and $309 for tirzepatide. The $109 and $209 you see first are a $100-off promotion on your first order, applied automatically — real, but not the standing rate. Every dose costs the same, so the number doesn't climb as you titrate up, and the prescription, injection supplies, clinician visit and two-day cold-chain shipping are all inside it with no separate membership fee.
- Who actually prescribes and compounds it?
- The Edit names both, which is rare enough to be the main reason to consider it. Clinical care is delivered by licensed providers at an affiliated practice called Arora Health & Aesthetics, LLC, and the medication is compounded by The Pharmacy Hub, a licensed US compounding pharmacy that batch-tests. The Edit itself operates as the management company and says plainly that it does not practice medicine.
- Is it available in Spanish?
- Yes, and properly — there is a complete Spanish version of the site rather than a translated landing page, covering the same guides, calculators and product pages. If Spanish is the language you'd rather read your medical information in, that is a genuine and uncommon advantage here.
- Can I get brand-name Wegovy or Zepbound?
- No. The Edit sells compounded semaglutide and tirzepatide only. Compounded versions are not FDA-approved as finished products and don't carry the pregnancy and lactation labeling the brand pens do — which matters if you are pregnant, trying to conceive or nursing, since the site has no guidance on any of those.
Pricing, states and verification reflect The Edit's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.